This report aims to assess the available evidence on the risk of tick-borne encephalitis virus (TBEV) transmission through substances of human origin (SoHO) such as blood, organs, tissues, and cells, and proposes potential safety measures.
ECDC has released an assessment on tick-borne encephalitis (TBE), focusing on the transmission risks of the TBE virus (TBEV) through substances of human origin (SoHO) such as blood, organs, tissues, and cells.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20 - 26 July and includes updates on Avian influenza A(H5N6), SARS-CoV-2 variant classification, Overview of respiratory virus epidemiology in the EU/EEA, Circulating vaccine-derived poliovirus type 2 (cVDPV2), cholera, Crimean-Congo haemorrhagic fever, Oropouche virus disease, Seasonal surveillance of West Nile virus infections, Mass gathering monitoring - Olympic and Paralympic Games, Nipah virus disease.
According to the latest ECDC Annual Epidemiological Report (AER) issued today, 3 650 tick-borne encephalitis (TBE) cases were reported in 20 EU/EEA countries in 2022. Most cases occurred between June and November, with July having the highest number of reported cases.
For 2022, 20 European Union/European Economic Area (EU/EEA) countries reported 3 650 cases of tick-borne encephalitis (TBE), 3 516 (96.3%) of which were confirmed.
